Physician profile
Salman Okour
NPI 1265691505
$8,878.65
in general payments reported to CMS, 2019-2025
10 companies · $8,472 in 2025
The $8,472 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $24.84 · 2022: $49.44 · 2024: $220 · 2025: $8,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,000 · Travel and Lodging: $444 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,000.00 |
| Travel and Lodging | $443.82 |
| Food and Beverage | $247.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Virtual Incision Corporation | $8,443.82 | 2025 | Mira |
| Ferring Pharmaceuticals INC. | $124.84 | 2024 | Menopur |
| Organon LLC | $94.96 | 2024 | |
| Myovant Sciences Gmbh | $49.44 | 2022 | |
| Abbvie INC. | $44.29 | 2019 | |
| Olympus America INC. | $35.81 | 2019 | |
| Applied Medical Resources Corporation | $27.84 | 2025 | Gelpoint V-Path |
| Bayer Healthcare Pharmaceuticals INC. | $24.84 | 2020 | |
| Roche Diagnostics Corporation | $20.00 | 2019 | |
| Therapeuticsmd, INC. | $12.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Salman Okour listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.